Michael Shlisky, an analyst from D.A. Davidson, reiterated the Buy rating on Blue Bird (BLBD – Research Report). The associated price ...

Eric Joseph has given his Hold rating due to a combination of factors surrounding Bluebird Bio’s portfolio and financial outlook. The recent publication in the New England Journal of Medicine ...

the insider now owns 80,617 shares of Blue Bird Corp. Blue Bird Corp, listed under the symbol BLBD, is a prominent manufacturer of school buses and related parts in the United States.

After bluebird bio acknowledged troubles keeping its business operational, the gene therapy biotech is launching a restructuring that will reduce the size of its workforce by about 25%.

Somerville gene therapy company Bluebird Bio on Tuesday announced a 25 percent reduction of its workforce as part of a restructuring meant to save money as it seeks to market its expensive but ...

September 24, 2024--(BUSINESS WIRE)--Following a comprehensive review of its operations, bluebird bio, Inc. (Nasdaq: BLUE) today announced that the Company is implementing a restructuring intended ...

View Blue Bird Corporation (BLBD) current and estimated P/E ratio data provided by Seeking Alpha.

Bluebird Care has undergone a rebrand with the strapline ‘it’s good to be home’. The homecare provider’s refreshed identity ...

Blue Bird Corporation’s stock has soared by over 530% from its 2023 lows. The company has benefited from Biden’s school buses funding. It has over 5,200 of order backlogs and ambitious margin ...